METASTATIC HEAD AND NECK CANCER
Clinical trials for METASTATIC HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise against HPV-driven head and neck cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs, PDS0101 and pembrolizumab, in 95 adults with a type of head and neck cancer linked to HPV16 that had returned or spread. The goal was to see if the combination could shrink tumors and improve survival. Participants had t…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated May 17, 2026 05:36 UTC
-
New drug combo shows promise for tough head and neck cancers
Disease control CompletedThis study tested a combination of two drugs, duvelisib and docetaxel, in 26 people with head and neck cancer that had come back or spread and could not be cured. The goal was to see if the combo could shrink tumors. Participants had already tried a type of immunotherapy called a…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated May 17, 2026 05:30 UTC